To evaluate the effects of RXDX-105 on neuroblastoma tumor vascularity, tumor samples were immunostained for vascular endothelial cells with anti-CD31 antibodies and mean vessel density was calculated in treated and untreated tumors. The gene discussed is PECAM1; the disease is neuroblastoma.